NCT04734262 2023-11-18
SPARK
Fudan University
Phase 2 Unknown
Clinical Trials
9 trialsNCT03567720 2023-06-01
Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
OncoSec Medical Incorporated
Phase 2 Unknown
NCT04355858 2022-07-26
MULAN
Fudan University
Phase 2 Unknown
NCT05429684 2022-06-23
Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer
First Affiliated Hospital Xi'an Jiaotong University
Phase 3 Unknown
NCT04745975 2022-04-20
Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer
Fudan University
Phase 2 Unknown
NCT05251766 2022-02-23
Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer
Zhejiang Provincial People's Hospital
Phase 1 Unknown
NCT04676997 2020-12-21
Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT00436709 2014-01-06
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
National Cancer Institute (NCI)
Phase NA Unknown
NCT00404404 2013-12-18
ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Unknown